European Society of Cardiology: cardiovascular disease statistics 2025

European Heart Journal

19 May 2026
Organised by: Logo
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Cardiac Care Acute Coronary Syndromes DISEASES OF THE AORTA, PERIPHERAL VASCULAR DISEASE, STROKE Arrhythmias, General Diseases of the Aorta Peripheral Vascular and Cerebrovascular Disease Stroke Public Health and Health Economics HEART FAILURE Chronic Heart Failure Atrial Fibrillation (AF) HYPERTENSION Device Therapy Cardiovascular Surgery Interventional Cardiology OTHER European Society of Cardiology VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Congenital Heart Disease and Paediatric Cardiology Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure Valvular Heart Disease

Abstract

Abstract

This 2025 report from the ESC Atlas project is the fifth in a biennial series. It presents and compares updated cardiovascular disease (CVD) statistics for more than 50 of the ESC member countries. The statistics are for 2024 or latest available year and are stratified by sex and World Bank national income status to identify inequalities in the risk, management, and outcomes of CVD across ESC member countries. A key objective of the ESC Atlas project has been to inform EU-level policy initiatives aimed at reducing the burden of CVD, contributing to the evidence base underpinning the European Union's cardiovascular health plan (“Safe Hearts Plan”), adopted in December 2025. Population ageing is a major contributor to the continuing high prevalence of CVD across ESC member countries. The Atlas reports 68 million disability-adjusted life years attributable to CVD in association with more than 3 million deaths per year. These statistics identify CVD as the leading cause of death across ESC member countries. However, substantial variation exists by national income status, with middle-income countries exhibiting age-standardized mortality rates that are roughly twice those observed in high-income countries. Marked disparities in healthcare delivery—particularly in workforce capacity and access to advanced interventions—are also evident. These inequalities by national income status are recurrent throughout this Atlas report. They highlight clear priorities for policymakers as they develop strategies to reduce the burden of CVD in the regions where the need is greatest. This 2025 report provides a detailed picture of the complex interplay between demography, the environment, socio-economic status, and clinical factors in shaping cardiovascular (CV) risk. It underscores how the progress that has been made in reducing the CVD burden across ESC member countries is at risk of being offset by new challenges, particularly the epidemic of obesity and diabetes that continues to undermine CV health. The findings presented in this report emphasize the need for coordinated policies to combat these challenges in order to sustain the progress that has been made in reducing the burden of CVD across ESC member countries.

Contributors

Steffen E Petersen
Steffen E Petersen

Author

Queen Mary University of London London , United Kingdom of Great Britain & Northern Ireland

Nathalie Conrad
Nathalie Conrad

Author

KU Leuven Leuven , Belgium

Agnieszka Kaplon-Cieslicka
Agnieszka Kaplon-Cieslicka

Author

Medical University of Warsaw Warsaw , Poland

Maryam Kavousi
Maryam Kavousi

Author

Erasmus University Medical Centre Rotterdam , Netherlands (The)

Marta Cvijic
Marta Cvijic

Author

University Medical Centre Ljubljana Ljubljana , Slovenia

Barbara Ignatiuk
Barbara Ignatiuk

Author

Humanitas Gavazzeni Hospital Bergamo , Italy

Daniel Scherr
Daniel Scherr

Author

Medical University of Graz Graz , Austria

Giuseppe Boriani
Giuseppe Boriani

Author

Modena Polyclinic Modena University Hospital Modena , Italy

Efstratios Karagiannidis
Efstratios Karagiannidis

Author

AHEPA General Hospital of Aristotle University Thessaloniki , Greece

Helmut Puererfellner
Helmut Puererfellner

Author

Ordensklinikum Linz Elisabethinen Linz , Austria

Thomas F Lüscher
Thomas F Lüscher

Author

Royal Brompton and Harefield NHS Foundation Trust London , United Kingdom of Great Britain & Northern Ireland